Cerebrovascular diseases (Basel, Switzerland) · 2025
Assessing Population-Based Radiological Brain Health in Stroke Epidemiology: Rationale and Design.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Khatri Pooja, Sucharew Heidi, Sawyer Russell P, Khandwala Vivek, Wang Lily Li-Li, Cornelius Rebecca, Gaskill-Shipley Mary, Tomsick Thomas A, Wang David, Gangatirkar Shantala, Williamson Brady Jamal, Maloney Thomas, Horn Paul, Carrozzella Janice, Alwell Kathleen, Haverbusch Mary, Kissela Brett M, Vagal Achala
Аннотация
INTRODUCTION: Approximately 20% of strokes in the USA are preceded by either a stroke or transient ischemic attack (TIA). Determining which stroke patients are at higher risk for recurrence allows for individualized, aggressive secondary stroke prevention. A comprehensive clinical decision tool, considering the full spectrum of radiological brain health including small vessel disease parameters, is currently lacking. Furthermore, large-scale characterization of preexisting radiological brain health may elucidate novel phenotypes. This study aims (1) to characterize imaging manifestations of brain health at a population level, and associated demographic and clinical risk factors at the time of index stroke and (2) to create a 90-day and 3-year prediction models of cerebrovascular disease recurrence (ischemic or hemorrhagic stroke) incorporating comprehensive parameters from routine clinical imaging.
METHODS: Our overall cohort was estimated to consist of 4,250 patients hospitalized with stroke, including 525 with hemorrhagic and 3,725 with ischemic/TIA subtypes, ascertained in the Greater Cincinnati/Northern Kentucky Stroke Study (GCNKSS) population of 1.4 million residents from January 1, 2015, to December 31, 2015. Among 3,725 ischemic stroke/TIA patients, based on published and ongoing data collection, we estimated that approximately 16% will have a recurrent ischemic or hemorrhagic stroke over the subsequent 3 years. Among these, 80% were estimated to have MR imaging (MRI) for review. Leveraging extensive clinical and demographic data already collected in the 2015 NIH-funded GCKNSS study, we will have obtained and centrally characterized MRI, acute CT, and vascular data in patients with hospitalized stroke/TIAs. We will determine if and how preexisting imaging parameters cluster using factor analysis, and identify associated demographic and clinical risk factors in multivariable modeling. We will develop short-term (90-day) and long-term (3-year) risk prediction models using the machine learning approach of random survival forest with internal validation, and perform Cox regression models as a sensitivity analysis.
CONCLUSION: The primary outcome is recurrence defined as any stroke (ischemic or hemorrhagic) occurring after index ischemic stroke or TIA event. For index ischemic strokes, the second event must within a different vascular territory if <14 days from the index event.
METHODS: Our overall cohort was estimated to consist of 4,250 patients hospitalized with stroke, including 525 with hemorrhagic and 3,725 with ischemic/TIA subtypes, ascertained in the Greater Cincinnati/Northern Kentucky Stroke Study (GCNKSS) population of 1.4 million residents from January 1, 2015, to December 31, 2015. Among 3,725 ischemic stroke/TIA patients, based on published and ongoing data collection, we estimated that approximately 16% will have a recurrent ischemic or hemorrhagic stroke over the subsequent 3 years. Among these, 80% were estimated to have MR imaging (MRI) for review. Leveraging extensive clinical and demographic data already collected in the 2015 NIH-funded GCKNSS study, we will have obtained and centrally characterized MRI, acute CT, and vascular data in patients with hospitalized stroke/TIAs. We will determine if and how preexisting imaging parameters cluster using factor analysis, and identify associated demographic and clinical risk factors in multivariable modeling. We will develop short-term (90-day) and long-term (3-year) risk prediction models using the machine learning approach of random survival forest with internal validation, and perform Cox regression models as a sensitivity analysis.
CONCLUSION: The primary outcome is recurrence defined as any stroke (ischemic or hemorrhagic) occurring after index ischemic stroke or TIA event. For index ischemic strokes, the second event must within a different vascular territory if <14 days from the index event.